Tilray Inc (TLRY)
$19.75
1.42 (6.71%)
TLRY Stock Quote Delayed 15 Minutes
Previous Close
$19.75
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
4.33M
Day's Range
19.38 - 21.45
52-Week Range
15.01 - 89.88
Dividend & Yield
N/A (N/A)
TLRY Stock Predictions, Articles, and Tilray Inc News
This Surge in Tilray Stock May Not Be a One-off Event
Among the marijuana losers of 2019, Tilray stock was one of the ugliest. However, with executive-level recruitments, along with a clearer roadway, this name can surprise investors.
Troubles for Aurora Cannabis Are Bound to Continue in 2020
After an unrelenting decline since the start of 2019, Aurora Cannabis (NYSE:ACB) may continue its dramatic drop in 2020. The sudden executive changes, a stock....
Why Canopy Growth Stock is a Buy Today as Cannabis’ Bad Year Nears End
It’s unlikely to be the next Netflix or Microsoft, but Canopy Growth stock has made the case for today’s investors to take a nibble
Why There’s No Rush to Buy Tilray Stock Anytime Soon
TLRY stock is down big since the passage of the MORE Act, and that's a sign of more troubles to come for Tilray stock.
Is the Right Move to Buy Hexo Stock Amid Cannabis Rebound?
Hexo stock is showing improvement on the charts, but we need a significant improvement given the lacking fundamentals and industry disdain.
Is Aurora Cannabis Stock Officially Back from the Dead?
With some recent bullish moves, Aurora Cannabis stock looks interesting as a contrarian trade. However, it has much to prove before anyone can offer a confident recommendation.
Investors Should Stop Calling Tilray Stock a Top-Tier Marijuana Name
Hope for U.S. legalization helped Tilray stock, but financial conditions indicate it may struggle to remain top-tier or perhaps, survive.
Don’t Buy Tilray Stock Despite the Cannabis Rebound
Despite the steep discount in Tilray stock, this remains a name to avoid because neither the fundamentals nor technicals imply a positive trajectory.
As Canopy Growth Stock Stalls, Pot Investors Mull What Will Happen Next?
Canopy Growth faces plenty of tough problems ahead. So too, do its competitors. When will outsized growth return to CGC?
Don’t Bet on Tilray Stock Surviving the Cannabisphere Meltdown
Tilray stock is a minefield of risk. "Cannabis 2.0" could improve their fortunes. But a myriad of risks remain. With $450 million in convertible notes coming due in 2023, TLRY needs to improve its cash situation. Unless the company is swimming in green (cash, not pot) by then, Tilray will need a capital infusion to stay afloat. Add in potential selling pressure from Privateer shareholders unloading their position, and there's too many fleas on this dog for my taste.
The Manitoba Harvest Acquisition Saved Tilray Stock This Quarter
Tilray’s acquisition of Manitoba Harvest should help Tilray stock. TLRY stock may perform better than other marijuana stocks.
Stock Market Today: Cannabis Gets Crushed
Walmart and Cisco stock beat on earnings, but fell on Thursday. Here's what happened in the stock market today.
Tilray Stock Has Fallen and Can’t Get Up
Tilray stock, along with the rest of the marijuana sector, have fallen out of favor and won't get back up. They need consistent profit.
High Hopes: Tilray Stock Needs a Miracle to Finish 2019 Strong
Investors justifiably have low expectations for TLRY stock ahead of quarterly earnings. Here's the outlook for Tilray through the end of 2019.
The Bubble Has Burst, But Tilray Stock Is More Than a Penny Stock
Tilray stock is hovering near its IPO level. The cannabis bubble has burst, but that doesn't mean TLRY should be treated like a penny stock.
Why the Slide of Tilray Stock May Continue
Tilray stock has been stuck in a multi-quarter decline, and the fundamentals imply that the slide of TLRY stock may not be over.
Is Tilray Stock About to Stage a Comeback?
Throughout 2019, Tilray stock and its cannabis peers have hemorrhaged market value. But a development within the sphere of cancer research has brought legitimacy to both TLRY and the broader industry.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
F
